Year-over-year earnings per share growth for the last twelve months: sol-gel.com (SLGL)

Sol-Gel Technologies, Ltd. - graphic logo of issuer SLGL

Microencapsulation patents and strict FDA oversight create significant barriers to entry for competitors. The amplitude of quarterly EPS fluctuations illustrates the impact of these advantages on profitability, where -127.20 captures the magnitude of this parameter. Stability is ensured by royalties from industry behemoths, while outsourcing production and testing to contractors allows Sol-Gel Technologies (SLGL) to focus on dermatological innovations.

Sol-Gel Technologies Ltd. (SLGL) Year-over-year net earnings per share change for the last twelve months: for the period 07/04/2022 - 11/11/2026

Financial and market metric breakdowns for Sol-Gel Technologies, Ltd. (SLGL)

- share price and expert price forecast:
Stock Price Sol-Gel Technologies Ltd.|SLGL - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value Sol-Gel|SLGL - Business Value
- book capitalization data:
Net Assets per Single Share Sol-Gel Technologies|SLGL - Book Valuation of Business|Market Value to Book Value Ratio sol-gel.com|SLGL - Company Assets
- debt and solvency information:
Debt to Equity Sol-Gel Technologies|SLGL - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Sol-Gel Technologies|SLGL - Company Total Indebtedness|Debts to Book Capitalization Sol-Gel|SLGL - Long-Term Indebtedness|Company Short-Term Debts Sol-Gel Technologies|Quick Liquidity sol-gel.com
- earnings and market multiples details:
SLGL - Company Net Income|Future Profit Sol-Gel Technologies|SLGL - Company Value to Net Income|Projected Price to Earnings Sol-Gel|SLGL - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Sol-Gel|SLGL - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Sol-Gel Technologies|SLGL - Net earnings per share for the last 12 months|Quarterly EPS earnings growth sol-gel.com|SLGL - Earnings per share increase in current year|Net earnings per share growth forecast for next year Sol-Gel Technologies
Fundamental company analysis:Sol-Gel Technologies Ltd. - SLGL
Manufactured product of sol-gel.com

Quarterly EPS growth measures the rate of change in net profit per share, allowing for an assessment of real capital generation efficiency relative to market value. Analyzing the quarterly EPS trend profile is critical for Sol-Gel Technologies (SLGL), as it exposes the company's financial resilience amid patent risks and dependence on the successful market launch of new dermatological products.

Competitors of Sol-Gel Technologies

KRYS: Quarterly EPS earnings growth|APGE - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Arcutis Biotherapeutics Inc|Year-over-year earnings per share growth for the last 12 months VCEL (Vericel Inc.)|Year-over-year earnings per share growth for the last twelve months Oruka Therapeutics Inc (ORKA)|Year-over-year net earnings per share change for the last twelve months sanaramedtech.com|Year-over-year earnings per share growth for the last twelve months DBV Technologies DBVT|Solesence Beauty (SLSN) - Earnings per share growth in annualized terms for the last twelve months|DERM - Year-over-year earnings per share growth for the last twelve months|FBRX: Year-over-year earnings per share growth for the last twelve months|EMPG (Empro Group Inc) - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year AXIL Brands AXIL|MDCX (Medicus Pharma) - Quarterly EPS earnings growth|VRCA - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth HOTH|BFRI - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months VYNE Therapeutics Inc. VYNE|Sonoma Pharmaceuticals Inc. - Year-over-year earnings per share growth for the last twelve months|QNRX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months AZTR (Azitra Inc)|DRMA (Dermata) - Year-over-year net earnings per share growth for the last 12 months|ELAB: Year-over-year earnings per share growth rate for the last twelve months|RVNC (Revance Therapeutics) - Quarterly EPS earnings growth